Viewing Study NCT00262834


Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2026-06-21 @ 1:09 AM
Study NCT ID: NCT00262834
Status: COMPLETED
Last Update Posted: 2020-02-19
First Post: 2005-12-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Stage I Breast Cancer View
None Stage II Breast Cancer View
None Stage III Breast Cancer View
Keywords: